Literature DB >> 18584569

Pregnancy and race/ethnicity as predictors of motivation for drug treatment.

Mary M Mitchell1, S Geoff Severtson, William W Latimer.   

Abstract

While drug use during pregnancy represents substantial obstetrical risks to mother and baby, little research has examined motivation for drug treatment among pregnant women. We analyzed data collected between 2000 and 2007 from 149 drug-using women located in Baltimore, Maryland. We hypothesized that pregnant drug-using women would be more likely than non-pregnant drug-using women to express greater motivation for treatment. Also, we explored race/ethnicity differences in motivation for treatment. Propensity score analysis was used to match a sample of 49 pregnant drug-using women with 100 non-pregnant drug-using women. The first logistic regression model indicated that pregnant women were more than four times as likely as non-pregnant women to express greater motivation for treatment. The second logistic regression analysis indicated a significant interaction between pregnancy status and race/ethnicity, such that white pregnant women were nearly eight times as likely as African-American pregnant women to score higher on the motivation for treatment measure. These results suggest that African-American pregnant drug-using women should be targeted for interventions that increase their motivation for treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18584569      PMCID: PMC2714164          DOI: 10.1080/00952990802082172

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  18 in total

1.  Drug problem recognition, desire for help, and treatment readiness in a soup kitchen population.

Authors:  Peter C Nwakeze; Stephen Magura; Andrew Rosenblum
Journal:  Subst Use Misuse       Date:  2002-02       Impact factor: 2.164

2.  The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.

Authors:  H E Jones; N Haug; K Silverman; M Stitzer; D Svikis
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

3.  Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.

Authors:  C G Schütz; E Rapiti; D Vlahov; J C Anthony
Journal:  Drug Alcohol Depend       Date:  1994-10       Impact factor: 4.492

4.  Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.

Authors:  Einat Peles; Miriam Adelson
Journal:  J Addict Dis       Date:  2006

Review 5.  Treatment issues for opioid-dependent women during the perinatal period.

Authors:  L P Finnegan
Journal:  J Psychoactive Drugs       Date:  1991 Apr-Jun

Review 6.  Female clients in substance abuse treatment.

Authors:  J C Marsh; N A Miller
Journal:  Int J Addict       Date:  1985 Jun-Jul

Review 7.  The consequences of prenatal substance use for the developing fetus, newborn, and young child.

Authors:  M Behnke; F D Eyler
Journal:  Int J Addict       Date:  1993-11

8.  Identifying pregnant women at risk for early attrition from substance abuse treatment.

Authors:  Wendy B Kissin; Dace S Svikis; Paula Moylan; Nancy A Haug; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2004-07

9.  The role of sexual transmission of HIV infection among injection and non-injection drug users.

Authors:  Steffanie A Strathdee; Susan G Sherman
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

10.  Does pregnancy affect outcome of methadone maintenance treatment?

Authors:  Cynthia Crandall; Ross D Crosby; Gregory A Carlson
Journal:  J Subst Abuse Treat       Date:  2004-06
View more
  8 in total

1.  Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity.

Authors:  Courtenay E Cavanaugh; William W Latimer
Journal:  Addict Disord Their Treat       Date:  2010-03

2.  Gender differences in access to methadone maintenance therapy in a Canadian setting.

Authors:  Paxton Bach; M-J Milloy; Paul Nguyen; John Koehn; Silvia Guillemi; Thomas Kerr; Evan Wood
Journal:  Drug Alcohol Rev       Date:  2015-03-04

3.  Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs.

Authors:  Elizabeth Evans; Libo Li; Jennifer Pierce; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2013-05-20

4.  A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.

Authors:  Paul Truman Harrell; R C Trenz; M Scherer; S S Martins; W W Latimer
Journal:  J Subst Abuse Treat       Date:  2013-05-22

5.  Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatment.

Authors:  Elizabeth Evans; Libo Li; Samantha Buoncristiani; Yih-Ing Hser
Journal:  Subst Use Misuse       Date:  2014-05-16       Impact factor: 2.164

Review 6.  Alcohol Consumption in Demographic Subpopulations: An Epidemiologic Overview.

Authors:  Erin Delker; Qiana Brown; Deborah S Hasin
Journal:  Alcohol Res       Date:  2016

7.  Incidence of Neonatal Abstinence Syndrome Epidemic and Associated Predictors in Nevada: A Statewide Audit, 2016-2018.

Authors:  Kavita Batra; Patricia Cruz; Chad L Cross; Neeraj Bhandari; Farooq Abdulla; Jennifer R Pharr; Mark P Buttner
Journal:  Int J Environ Res Public Health       Date:  2020-12-30       Impact factor: 3.390

8.  Patterns of psychiatric admission in Australian pregnant and childbearing women.

Authors:  Marie-Paule Austin; Taryn L Ambrosi; Nicole Reilly; Maxine Croft; Jolie Hutchinson; Natasha Donnolley; Cathrine Mihalopoulos; Mary Lou Chatterton; Georgina M Chambers; Elizabeth Sullivan; Catherine Knox; Fenglian Xu; Nicole Highet; Vera A Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-07-22       Impact factor: 4.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.